Medical Teams International

Audits
3
Findings
32
Total Expended
$34.85M
Latest Accepted
2025-09-11
Location: Tigard, OR
UEI: MYGWXNWZNL65 EIN: 930878944

SAM.gov Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Sam Wehbe Chief Financial Officer Auditee
Andrea Chung Managing Director Auditee
Paige Hagen Audit Managing Director Auditee
Bryce Rassilyer Principal Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
366111 2024 2025-09-11 Cliftonlarsonallen LLP $13.21M
308679 2023 2024-06-12 Kpmg $11.63M
16949 2022 2023-03-30 Kpmg $10.01M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
366111 2024 2025-09-11 1152639 2024-001 Significant Deficiency - BH
366111 2024 2025-09-11 1152638 2024-001 Significant Deficiency - BH
366111 2024 2025-09-11 1152637 2024-001 Significant Deficiency - BH
366111 2024 2025-09-11 576197 2024-001 Significant Deficiency - BH
366111 2024 2025-09-11 576196 2024-001 Significant Deficiency - BH
366111 2024 2025-09-11 576195 2024-001 Significant Deficiency - BH
308679 2023 2024-06-12 977082 2023-002 Material Weakness - C
308679 2023 2024-06-12 977081 2023-002 Material Weakness - C
308679 2023 2024-06-12 977080 2023-002 Material Weakness - C
308679 2023 2024-06-12 977079 2023-002 Material Weakness - C
308679 2023 2024-06-12 977078 2023-002 Material Weakness - C
308679 2023 2024-06-12 977077 2023-002 Material Weakness - C
308679 2023 2024-06-12 977076 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 977075 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 977074 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 977073 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 977072 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 977071 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 400640 2023-002 Material Weakness - C
308679 2023 2024-06-12 400639 2023-002 Material Weakness - C
308679 2023 2024-06-12 400638 2023-002 Material Weakness - C
308679 2023 2024-06-12 400637 2023-002 Material Weakness - C
308679 2023 2024-06-12 400636 2023-002 Material Weakness - C
308679 2023 2024-06-12 400635 2023-002 Material Weakness - C
308679 2023 2024-06-12 400634 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 400633 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 400632 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 400631 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 400630 2023-001 Significant Deficiency - C
308679 2023 2024-06-12 400629 2023-001 Significant Deficiency - C
16949 2022 2023-03-30 588911 2022-001 Significant Deficiency - L
16949 2022 2023-03-30 12469 2022-001 Significant Deficiency - L